RXST
RxSight Inc.
$8.79
+$0.20(+2.33%)
57
Overall
60
Value
54
Tech
--
Quality
Market Cap
$360.47M
Volume
459.55K
52W Range
$6.32 - $55.57
Target Price
$8.89
Order:
Income Statement
| Metric | Trend | Chart | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Total Revenue | $22.6M | $49.0M | $89.1M | $139.9M | ||
| Total Revenue | $22.6M | $49.0M | $89.1M | $139.9M | ||
| COST OF GOODS SOLD | ||||||
| Cost of Revenue | $18.1M | $27.7M | $35.3M | $41.0M | ||
| GROSS PROFIT | ||||||
| Gross Profit | $4.5M | $21.3M | $53.8M | $98.9M | ||
| OPERATING EXPENSES | ||||||
| Operating Expenses | $57.3M | $84.6M | $103.8M | $135.8M | ||
| Research & Development | $24.5M | $26.0M | $29.1M | $34.4M | ||
| Research Expense | $24.5M | $26.0M | $29.1M | $34.4M | ||
| Selling, General & Administrative | $32.8M | $58.7M | $74.8M | $101.4M | ||
| General & Administrative Expenses | $32.8M | $58.7M | $74.8M | $101.4M | ||
| Other Operating Expenses | $-459.0K | $-481.0K | $-683.0K | $-1.3M | ||
| OPERATING INCOME | ||||||
| Operating income | $-52.8M | $-63.3M | $-50.1M | $-36.9M | ||
| EBITDA | $-40.5M | $-57.2M | $-40.8M | $-23.8M | ||
| NON-OPERATING ITEMS | ||||||
| Interest Expense (Non-Operating) | $3.7M | $4.9M | $3.3M | $21.0K | ||
| Intinc | $54.0K | $1.5M | $6.6M | $9.5M | ||
| Net Non-Operating Interest Income/Expense | $-3.6M | $-3.4M | $3.3M | $9.5M | ||
| Gain on Sale of Securities | $9.0K | $75.0K | $10.0K | $190.0K | ||
| Other Income/Expense | $2.7M | $-75.0K | $1.8M | $-190.0K | ||
| Other Special Charges | $-2.7M | -- | $-1.8M | -- | ||
| PRE-TAX INCOME | ||||||
| EBIT | $-45.0M | $-61.8M | $-45.3M | $-27.4M | ||
| Pre-Tax Income | $-48.7M | $-66.7M | $-48.6M | $-27.4M | ||
| INCOME TAX | ||||||
| Tax Provision | $8.0K | $9.0K | $20.0K | $50.0K | ||
| NET INCOME | ||||||
| Net Income | $-48.7M | $-66.8M | $-48.6M | $-27.5M | ||
| Net Income (Continuing Operations) | $-48.7M | $-66.8M | $-48.6M | $-27.5M | ||
| Net Income (Discontinued Operations) | $-48.7M | $-66.8M | $-48.6M | $-27.5M | ||
| Net Income (Common Stockholders) | $-59.1M | $-66.8M | $-48.6M | $-27.5M | ||
| Normalized Income | $-38.5M | -- | -- | -- | ||
| TOTALS | ||||||
| Total Expenses | $75.4M | $112.3M | $139.2M | $176.8M | ||
| SHARE & EPS DATA | ||||||
| Average Shares Outstanding | $13.6M | $27.7M | $34.5M | $38.9M | ||
| Average Shares Outstanding (Diluted) | $13.6M | $27.7M | $34.5M | $38.9M | ||
| Shares Outstanding | $27.4M | $33.8M | $37.0M | $40.5M | ||
| Basic EPS | $-3.57 | $-2.41 | $-1.41 | $-0.71 | ||
| Basic EPS (Continuing Operations) | $-3.57 | $-2.41 | $-1.41 | $-0.71 | ||
| Diluted EPS | $-3.57 | $-2.41 | $-1.41 | $-0.71 | ||
| Diluted EPS (Continuing Operations) | $-3.57 | $-2.41 | $-1.41 | $-0.71 | ||
| OTHER METRICS | ||||||
| Minority Interests | $138.2M | -- | -- | -- | ||
| Other Gand A | $32.8M | $58.7M | $74.8M | $101.4M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RXST | $8.79 | +2.3% | 459.55K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |